Detalhe da pesquisa
1.
Absorption, metabolism and excretion of [14C]omarigliptin, a once-weekly DPP-4 inhibitor, in humans.
Xenobiotica
; 48(6): 584-591, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28665228
2.
The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms.
J Allergy Clin Immunol
; 141(2): 785-788.e9, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28911971
3.
Effect of aprepitant on the pharmacokinetics of intravenous midazolam.
J Clin Pharmacol
; 47(6): 744-50, 2007 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-17463213
4.
Pharmacokinetic and Pharmacodynamic Effects of Multiple-dose Administration of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor, in Obese Participants With and Without Type 2 Diabetes Mellitus.
Clin Ther
; 38(3): 516-30, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26869191
5.
Placebo- and amitriptyline-controlled evaluation of central nervous system effects of the NK1 receptor antagonist aprepitant and intravenous alcohol infusion at pseudo-steady state.
J Clin Pharmacol
; 53(8): 846-56, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23775877
6.
A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer.
Cancer Chemother Pharmacol
; 70(4): 567-74, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22878520